Bayram, E. Et Al. 2023. Comparison of the effectiveness of liposomal doxorubicin and gemcitabine in patients with platinum-sensitive recurrent ovarian cancer receiving third-line chemotherapy.. European review for medical and pharmacological sciences , vol.27, no.14 , 6618-6626.

Bayram, E., Khatib, G., Kuçukgoz-Gulec, U., Guzel, A. B., Vardar, M. A., & Paydas, S., (2023). Comparison of the effectiveness of liposomal doxorubicin and gemcitabine in patients with platinum-sensitive recurrent ovarian cancer receiving third-line chemotherapy.. European review for medical and pharmacological sciences , vol.27, no.14, 6618-6626.

Bayram, ERTUĞRUL Et Al. "Comparison of the effectiveness of liposomal doxorubicin and gemcitabine in patients with platinum-sensitive recurrent ovarian cancer receiving third-line chemotherapy.," European review for medical and pharmacological sciences , vol.27, no.14, 6618-6626, 2023

Bayram, ERTUĞRUL Et Al. "Comparison of the effectiveness of liposomal doxorubicin and gemcitabine in patients with platinum-sensitive recurrent ovarian cancer receiving third-line chemotherapy.." European review for medical and pharmacological sciences , vol.27, no.14, pp.6618-6626, 2023

Bayram, E. Et Al. (2023) . "Comparison of the effectiveness of liposomal doxorubicin and gemcitabine in patients with platinum-sensitive recurrent ovarian cancer receiving third-line chemotherapy.." European review for medical and pharmacological sciences , vol.27, no.14, pp.6618-6626.

@article{article, author={ERTUĞRUL BAYRAM Et Al. }, title={Comparison of the effectiveness of liposomal doxorubicin and gemcitabine in patients with platinum-sensitive recurrent ovarian cancer receiving third-line chemotherapy.}, journal={European review for medical and pharmacological sciences}, year=2023, pages={6618-6626} }